Location History:
- Ulsan, KR (2018)
- Goyang-si, KR (2019 - 2021)
Company Filing History:
Years Active: 2018-2021
Title: The Innovative Contributions of Ho-Sik Oh
Introduction
Ho-Sik Oh is a prominent inventor based in Goyang-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of seven patents to his name, his work focuses on developing innovative methods and antibodies that enhance cancer therapies.
Latest Patents
Among his latest patents is the development of anti-human 4-1BB antibodies and their uses. This invention provides anti-human 4-1BB antibodies and fragments that possess unique structural features not found in reference antibodies. These features may improve the antibody's characteristics, making it more effective in inducing T-cell proliferation and secretion of IFN-γ. Additionally, it offers methods for detecting, preventing, and treating cancer using these antibodies. Another notable patent involves a method for isolating and proliferating autologous cancer antigen-specific CD8T cells. This method allows for the selection of epitopes recognized by CD8T cells from autologous cancer antigens in the blood of cancer patients. By utilizing T cells that recognize the patient's own cancer antigens, this approach aims to effectively target and eliminate cancer cells without causing side effects.
Career Highlights
Ho-Sik Oh has worked with notable organizations such as Eutilex Co., Ltd. and the National Cancer Center. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects that aim to improve cancer treatment methodologies.
Collaborations
Some of his notable coworkers include Byoung S Kwon and Kwang-Hui Kim. Their collaborative efforts have contributed to the advancement of innovative solutions in the field of cancer research.
Conclusion
Ho-Sik Oh's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for advancements in cancer therapies.